• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Suppression of colon cancer stemness by caudal-related homeobox transcription factors CDX1 and CDX2

Research Project

Project/Area Number 18K06955
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49010:Pathological biochemistry-related
Research InstitutionUniversity of Fukui

Principal Investigator

Kazuya Hori  福井大学, 学術研究院医学系部門, 助教 (50749059)

Co-Investigator(Kenkyū-buntansha) 青木 耕史  福井大学, 学術研究院医学系部門, 教授 (40402862)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords大腸癌 / CDX1 / CDX2 / 癌幹細胞 / LGR5 / 腫瘍学
Outline of Final Research Achievements

Caudal-related homeobox transcription factors CDX1 and CDX2 are expressed specifically in the intestinal epithelial cells and essential for their development and homeostasis. In this study, we have investigated the mechanisms by which CDX1 and CDX2 suppressed malignant progression of colorectal tumorigenesis, and found that they suppressed cancer stemness of colon cancer cells. We have also found that CDX1 and CDX2 suppressed expression of cancer stemness-related genes directly but not through typical epigenetic mechanisms such as histone modification, suggesting a new mechanism that controls colon cancer stemness.

Academic Significance and Societal Importance of the Research Achievements

本研究では、腸管の上皮細胞の恒常性の維持に重要な役割を担うCDX1やCDX2が、大腸癌の悪性化や腫瘍幹細胞性を抑制することを見出した。また、その機構として、CDX1やCDX2が、典型的なエピジェネティックな遺伝子発現制御とは異なる機構により、大腸癌の腫瘍幹細胞性に関わる遺伝子の発現を制御していることを見出した。すなわち、従来の研究からは分からなかった、新たな大腸癌の悪性化や腫瘍幹細胞性の制御機構が解明できる可能性があり、新たな治療標的の同定などが期待できる。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (4 results)

All 2020 2019 2018 Other

All Journal Article (1 results) (of which Peer Reviewed: 1 results) Presentation (2 results) (of which Invited: 1 results) Remarks (1 results)

  • [Journal Article] Blocking LC3 lipidation and ATG12 conjugation reactions by ATG7 mutant protein containing C572S2019

    • Author(s)
      Nitta A, Hori K, Tanida I, Igarashi A, Deyama Y, Ueno T, Kominami E, Sugai M, Aoki K.
    • Journal Title

      Biochem Biophys Res Commun.

      Volume: 508(2) Issue: 2 Pages: 521-526

    • DOI

      10.1016/j.bbrc.2018.11.158

    • Related Report
      2018 Research-status Report
    • Peer Reviewed
  • [Presentation] Mechanism that controls colon cancer stemness, via PAF1 complex through a competition between β-catenin and CDX1/22020

    • Author(s)
      Koji Aoki
    • Organizer
      第79回日本癌学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Suppression of intestinal cancer stemness and malignant progression by intestine-specific homeoproteins CDX1 and CDX22018

    • Author(s)
      Kazuya Hori, Mako Nakaya, Takanori Goi, Akio Yamaguchi, Shunichiro Iemura, Tohru Natsume, Makoto M. Taketo, Manabu Sugai, Koji Aoki
    • Organizer
      Looking to the future of Developmental Cell Biology Symposium
    • Related Report
      2018 Research-status Report
    • Invited
  • [Remarks] 福井大学医学部薬理学分野ホームページ

    • URL

      https://www.med.u-fukui.ac.jp/laboratory/pharmacology/

    • Related Report
      2020 Annual Research Report 2019 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi